Press Releases Quanterix Corporation

Equities

QTRX

US74766Q1013

Real-time Estimate Cboe BZX Other stock markets 19:19:20 08/05/2024 BST			5-day change	1st Jan Change
15.8 ^USD	-8.96%		-3.21%	-41.62%

05-07	Earnings Flash (QTRX) QUANTERIX CORPORATION Posts Q1 Revenue $32.1M, vs. Street Est of $31.5M	MT
05-07	Quanterix Corporation Provides Earnings Guidance for the Full-Year 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Quanterix Releases Financial Results for the First Quarter of 2024	05-07	BU
Quanterix To Report First Quarter 2024 Financial Results	04-29	BU
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure	03-21	BU
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease	03-04	BU
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023	02-29	BU
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance	02-26	BU
Quanterix to Present at Cowen's 44th Annual Health Care Conference	02-26	AQ
Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease	02-26	BU
Quanterix to Present at Cowen’s 44th Annual Health Care Conference	02-23	BU
Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call	02-16	BU
Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference	12-12	BU
Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum	11-13	BU
Quanterix Releases Operating Results for Third Quarter 2023	11-06	BU
Quanterix to Report Third Quarter 2023 Financial Results on November 7, 2023	30/10/23	BU
Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer’s Disease	24/10/23	BU
Quanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease Detection	24/10/23	BU
Quanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease Day	28/09/23	BU
Mercy BioAnalytics Adds Marketing and Portfolio Management Leadership to Support Diagnostic Test Development and Commercialization	12/09/23	AQ
Quanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference	05/09/23	BU
William P. Donnelly Appointed to Quanterix's Board of Directors	22/08/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Quanterix Corporation

Equities

QTRX

US74766Q1013

Press Releases

Filters